Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
Magnetic Resonance in Medicine|August 9, 2017
Application of pattern recognition techniques for classification of pediatric brain tumors by in vivo 3T 1 H-MR spectroscopy-A multi-center studyNiloufar Zarinabad, Laurence J Abernethy, Shivaram Avula, et al.
NMR in Biomedicine|March 17, 2024
Noise suppression of proton magnetic resonance spectroscopy improves paediatric brain tumour classificationTeddy Zhao, James T Grist, Dorothee P Auer, et al.
The Lancet. Oncology|May 27, 2017
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort studyEdward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2020
Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicityChase C Suiter, Takaya Moriyama, Kenneth A Matreyek, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Blood Advances|July 14, 2019
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motifPeixun Zhou, Alex E Blain, Alexander M Newman, et al.
NMR in Biomedicine|January 28, 2022
Metabolite selection for machine learning in childhood brain tumour classificationDadi Zhao, James T Grist, Heather E L Rose, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor ActivityKevin K-C Liu, JinJiang Zhu, Graham L Smith, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agentsPaul S Humphries, Simon Bailey, Jonathon V Almaden, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug DesignHengmiao Cheng, Chunze Li, Simon Bailey, et al.
Pageof 40